Programs, exercise technique and load planning.
BCAA and the liver and kidneys: why branched-chain amino acids are metabolized in muscle, their therapeutic use in cirrhosis, the nitrogen load on the kidneys, and risks in CKD and rare diseases.
The legal status of trenbolone acetate in Ukraine and the EU: no registration for human use, Directive 96/22/EC, national laws, the WADA ban. An editorial overview.
Creatine or HMB — which to choose for a strength athlete, a beginner, an older person, or a weight-class athlete. A practical breakdown from the editorial team with doses from research.
How ostarine (enobosarm, MK-2866, GTx-024) was created: from the discovery of nonsteroidal androgens to the failure of phase III, new indications, and the reasons why the drug is still not registered.
Electrolyte supplements and the kidneys and liver: how the kidneys regulate sodium, potassium, and magnesium, when an excess is dangerous, hyponatremia, medications, and tests. An editorial breakdown.
Why water loading, cutting out salt, and diuretics before a bodybuilding competition are dangerous: physiology, electrolyte disturbances, arrhythmias, and evidence-based recommendations.
Do essential phospholipids affect athletic performance: choline during prolonged exertion, phosphatidylserine and phosphatidic acid, research data, WADA status, and realistic expectations.
The vitamin D (25-OH) test: what it shows, how it differs from 1,25(OH)₂D, how vitamin D affects an athlete's bones, muscles, and immunity, and how to read the thresholds.
Anemia: how to prevent iron deficiency, which tests to take (hemoglobin, ferritin, transferrin saturation), warning symptoms, and when to see a doctor.
Interactions of amlodipine with other medications and supplements: CYP3A4 inhibitors and inducers, simvastatin, clarithromycin, tacrolimus, sildenafil, grapefruit, NSAIDs, and stimulants. What patients and athletes should know.
BCAA and the liver and kidneys: why branched-chain amino acids are metabolized in muscle, their therapeutic use in cirrhosis, the nitrogen load on the kidneys, and risks in CKD and rare diseases.
The legal status of trenbolone acetate in Ukraine and the EU: no registration for human use, Directive 96/22/EC, national laws, the WADA ban. An editorial overview.
